Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10825 - 10832 of 12011 results
Year End Employee Benefits Highlight: Good Plan Document Distribution Practices for Health and Welfare Plans
October 24, 2013| Blog| Viewpoint
EEOC Priorities May Place Staffing Firms Under Greater Scrutiny
October 24, 2013| Blog| Viewpoint
Another major medical data breach in California
October 24, 2013| Blog| Viewpoint
NCAA Gives Deference To The U – How Sanctions Against Miami May Affect Future Investigations
October 23, 2013| Blog| Viewpoint
Protecting an Employer From Corporate Criminal Liability for the Actions of Employees
October 23, 2013| Blog| Viewpoint
Paid Sick Leave Comes to New Jersey’s Second Largest City – Jersey City; is Newark, its Largest City Next?
October 23, 2013| Blog| Viewpoint
Mintz's Tom Burton to Moderate Energy Panel at Boston College - Friday, October 25
October 23, 2013| Blog| Viewpoint
FTC and the "Internet of Things": Franchisor on the hook
October 23, 2013| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|